无创生物标志物在子宫内膜异位症诊断中的应用进展
Application Progress of Noninvasive Biomarkers in the Diagnosis of Endometriosis
DOI: 10.12677/ACM.2023.132389, PDF,   
作者: 王文娜, 陈志芳*：新疆医科大学第一附属医院，新疆 乌鲁木齐
关键词: 子宫内膜异位症；生物标志物；Endometriosis； Biomarker
摘要: 子宫内膜异位症作为一种育龄期妇女常见疾病，近年来呈明显上升趋势。其发病机制在很大程度上仍不清楚，且诊断治疗难度大，术后复发率高，严重影响患者的生活质量及身心健康。腹腔镜下直视、活检病理确诊仍是目前内异症诊断的金标准。目前临床上越来越多关于非侵入性指标的研究有望减少内异症的诊断延迟，但至今尚未发现敏感性和特异性均较高的理想指标。非侵入性方法的新组合以及对新的生物标志物的进一步探索可能成为未来的研究热点，本文对近年来有关内异症非侵入性诊断方法及生物标记物的研究进展予以综述。
Abstract: Endometriosis, as a common disease in women of childbearing age, has shown a significant upward trend in recent years. Its pathogenesis is still largely unclear, and the diagnosis and treatment are difficult, and the recurrence rate is high, which seriously affects the quality of life and physical and mental health of patients. Laparoscopic direct vision and biopsy are still the gold standard for the diagnosis of endometriosis. At present, more and more clinical studies on non- invasive indicators are expected to reduce the diagnostic delay of endometriosis, but no ideal indicators with high sen-sitivity and specificity have been found. New combinations of noninvasive methods and further ex-ploration of new biomarkers may become research hotspots in the future. This article reviews the research progress of noninvasive diagnostic methods and biomarkers for endometriosis in recent years.
文章引用：王文娜, 陈志芳. 无创生物标志物在子宫内膜异位症诊断中的应用进展[J]. 临床医学进展, 2023, 13(2): 2759-2764. https://doi.org/10.12677/ACM.2023.132389

参考文献

[1] Taylor, H.S., Kotlyar, A.M. and Flores, V.A. (2021) Endometriosis Is a Chronic Systemic Disease: Clinical Challenges and Novel Innovations. The Lancet, 397, 839-852. [Google Scholar] [CrossRef] 
[2] 郎景和. 对子宫内膜异位症认识的历史、现状与发展[J]. 中国实用妇科与产科杂志, 2020, 36(3): 193-196.
[3] Kiesel, L. and Sourouni, M. (2019) Diagnosis of Endometriosis in the 21st Century. Climacteric, 22, 296-302. [Google Scholar] [CrossRef] [PubMed]
[4] Anastasiu, C.V., Moga, M.A., Elena Neculau, A., et al. (2020) Biomarkers for the Noninvasive Diagnosis of Endometriosis: State of the Art and Future Perspectives. Interna-tional Journal of Molecular Sciences, 21, Article No. 1750. [Google Scholar] [CrossRef] [PubMed]
[5] Fassbender, A., Burney, R.O., O, D.F., D’Hooghe, T. and Giudice, L. (2015) Update on Biomarkers for the Detection of Endometriosis. BioMed Research International, 2015, Article ID: 130854. [Google Scholar] [CrossRef] [PubMed]
[6] Oliveira, M.A.P., Raymundo, T.S., Soares, L.C., et al. (2017) How to Use CA-125 More Effectively in the Diagnosis of Deep Endometriosis. BioMed Research International, 2017, Article ID: 9857196. [Google Scholar] [CrossRef] [PubMed]
[7] Tian, Z., Chang, X.-H., Zhao, Y. and Zhu, H.-L. (2020) Current Bi-omarkers for the Detection of Endometriosis. Chinese Medical Journal, 133, 2346-2352. [Google Scholar] [CrossRef] 
[8] Somigliana, E., Viganò, P., Tirelli, A.S., et al. (2004) Use of the Concomitant Serum Dosage of CA 125, CA 19-9 and Interleukin-6 to Detect the Presence of Endometriosis. Re-sults from a Series of Reproductive Age Women Undergoing Laparoscopic Surgery for Benign Gynaecological Condi-tions. Human Reproduction, 19, 1871-1876. [Google Scholar] [CrossRef] [PubMed]
[9] Mosbah, A., Nabiel, Y. and Khashaba, E. (2016) Interleukin-6, Intra-cellular Adhesion Molecule-1, and Glycodelin A Levels in Serum and Peritoneal Fluid as Biomarkers for Endometriosis. International Journal of Gynecology & Obstetrics, 134, 247-251. [Google Scholar] [CrossRef] [PubMed]
[10] Rocha, A.L.L., Carrarelli, P., Novembri, R., et al. (2011) Altered Expression of Activin, Cripto, and Follistatin in the Endometrium of Women with Endometrioma. Fertility and Sterility, 95, 2241-2246. [Google Scholar] [CrossRef] [PubMed]
[11] Reis, F.M., Luisi, S., Abrão, M.S., et al. (2012) Diagnostic Value of Serum Activin A and Follistatin Levels in Women with Peritoneal, Ovarian and Deep Infiltrating Endometriosis. Human Reproduction, 27, 1445-1450. [Google Scholar] [CrossRef] [PubMed]
[12] Aznaurova, Y.B., Zhumataev, M.B., Roberts, T.K., Aliper, A.M. and Zhavoronkov, A.A. (2014) Molecular Aspects of Development and Regulation of Endometriosis. Reproductive Biology and Endocrinology, 12, Article No. 50. [Google Scholar] [CrossRef] [PubMed]
[13] Eisenberg, V.H., Zolti, M. and Soriano, D. (2012) Is There an As-sociation between Autoimmunity and Endometriosis? Autoimmunity Reviews, 11, 806-814. [Google Scholar] [CrossRef] [PubMed]
[14] Itoh, H., Sashihara, T., Hosono, A., Kaminogawa, S. and Uchida, M. (2011) Interleukin-12 Inhibits Development of Ectopic Endometriotic Tissues in Peritoneal Cavity via Activation of NK Cells in a Murine Endometriosis Model. Cytotechnology, 63, 133-141. [Google Scholar] [CrossRef] [PubMed]
[15] Kuessel, L., Wenzl, R., Proestling, K., et al. (2017) Soluble VCAM-1/Soluble ICAM-1 Ratio Is a Promising Biomarker for Diagnosing Endometriosis. Human Reproduction, 32, 770-779. [Google Scholar] [CrossRef] [PubMed]
[16] Luisi, S., Pinzauti, S., Regini, C. and Petraglia, F. (2015) Serum Markers for the Noninvasive Diagnosis of Endometriosis. Women’s Health, 11, 603-610. [Google Scholar] [CrossRef] [PubMed]
[17] Cho, S., Cho, H., Nam, A., et al. (2008) Neutrophil-to-Lymphocyte Ratio as an Adjunct to CA-125 for the Diagnosis of Endometriosis. Fertility and Sterility, 90, 2073-2079. [Google Scholar] [CrossRef] [PubMed]
[18] Coutinho, L.M., Ferreira, M.C., Rocha, A.L.L., Carneiro, M.M. and Reis, F.M. (2019) New Biomarkers in Endometriosis. Advances in Clinical Chemistry, 89, 59-77. [Google Scholar] [CrossRef] [PubMed]
[19] Hirsch, M. and Davis, C.J. (2015) Preoperative Assessment and Diagnosis of Endometriosis: Are We Any Closer? Current Opinion in Obstetrics & Gynecology, 27, 284-290. [Google Scholar] [CrossRef] 
[20] Nisenblat, V., Bossuyt, P.M.M., Shaikh, R., et al. (2016) Blood Biomarkers for the Non-Invasive Diagnosis of Endometriosis. The Cochrane Database of Systematic Reviews, No. 5, Article ID: CD012179. [Google Scholar] [CrossRef] 
[21] Carvalho, L.F.P., Samadder, A.N., Agarwal, A., Fernandes, L.F.C. and Abrão, M.S. (2012) Oxidative Stress Biomarkers in Patients with Endometriosis: Systematic Review. Ar-chives of Gynecology and Obstetrics, 286, 1033-1040. [Google Scholar] [CrossRef] [PubMed]
[22] Amreen, S., Kuma, P., Gupta, P. and Rao, P. (2019) Evaluation of Oxidative Stress and Severity of Endometriosis. Journal of Human Reproductive Sciences, 12, 40-46. [Google Scholar] [CrossRef] 
[23] Thézénas, M.L., De Leo, B., Laux-Biehlmann, A., et al. (2020) Author Correction: Amine Oxidase 3 Is a Novel Pro- Inflammatory Marker of Oxidative Stress in Peritoneal Endometri-osis Lesions. Scientific Reports, 10, Article No. 5665. [Google Scholar] [CrossRef] [PubMed]
[24] Wei, S., Xu, H. and Kuang, Y. (2015) Systematic Enrichment Analysis of microRNA Expression Profiling Studies in Endometriosis. Iranian Journal of Basic Medical Sciences, 18, 423-429.
[25] Bjorkman, S. and Taylor, H.S. (2019) MicroRNAs in Endometriosis: Biological Function and Emerging Biomarker Candidates†. Biology of Reproduction, 100, 1135-1146. [Google Scholar] [CrossRef] [PubMed]
[26] Cosar, E., Mamillapalli, R., Ersoy, G.S., et al. (2016) Serum microRNAs as Diagnostic Markers of Endometriosis: A Compre-hensive Array-Based Analysis. Fertility and Sterility, 106, 402-409. [Google Scholar] [CrossRef] [PubMed]
[27] Moustafa, S., Burn, M., Mamillapalli, R., et al. (2020) Accu-rate Diagnosis of Endometriosis Using Serum microRNAs. American Journal of Obstetrics and Gynecology, 223, 557.e1-557.e11. [Google Scholar] [CrossRef] [PubMed]
[28] Hudson, Q.J., Perricos, A., Wenzl, R. and Yotova, I. (2020) Challenges in Uncovering Non-Invasive Biomarkers of Endometriosis. Experimental Biology and Medicine, 245, 437-447. [Google Scholar] [CrossRef] [PubMed]
[29] Zhou, L., Chen, Y., Gao, J., et al. (2020) Diagnos-tic Value of Circulating MicroRNAs for Endometriosis: A Meta-Analysis. Reproductive Sciences, 27, 793-805. [Google Scholar] [CrossRef] [PubMed]

为你推荐